Tokyo Tape
Sign in
← Chiome Bioscience

Quarterly report · Q2

4583.TEDINET S100OXYH
Period2022-01-01 → 2022-06-30
Filed2022-08-10
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 45
MetricValuePeriodScopeSource row
Revenue¥278m2022-01-01 → 2022-06-30StandaloneNet sales
Revenue¥713m2021-01-01 → 2021-12-31StandaloneNet sales (5-year summary)
Revenue¥385m2021-01-01 → 2021-06-30StandaloneNet sales
Operating income−¥779m2022-01-01 → 2022-06-30StandaloneOperating income
Operating income−¥415m2021-01-01 → 2021-06-30StandaloneOperating income
Ordinary income−¥769m2022-01-01 → 2022-06-30StandaloneOrdinary income
Ordinary income−¥1.3bn2021-01-01 → 2021-12-31StandaloneOrdinary income loss (5-year summary)
Ordinary income−¥409m2021-01-01 → 2021-06-30StandaloneOrdinary income
Profit before tax−¥769m2022-01-01 → 2022-06-30StandaloneIncome before income taxes
Profit before tax−¥397m2021-01-01 → 2021-06-30StandaloneIncome before income taxes
Net income−¥771m2022-01-01 → 2022-06-30StandaloneProfit loss
Net income−¥1.5bn2021-01-01 → 2021-12-31StandaloneNet income loss (5-year summary)
Net income−¥409m2021-01-01 → 2021-06-30StandaloneProfit loss
Total assets¥1.9bnat 2022-06-30StandaloneAssets
Total assets¥2.3bnat 2021-12-31StandaloneAssets
Total assets¥3.3bnat 2021-06-30StandaloneTotal assets (5-year summary)
Total liabilities¥444mat 2022-06-30StandaloneLiabilities
Total liabilities¥446mat 2021-12-31StandaloneLiabilities
Net assets / equity¥1.5bnat 2022-06-30StandaloneNet assets
Net assets / equity¥1.9bnat 2021-12-31StandaloneNet assets
Net assets / equity¥2.9bnat 2021-06-30StandaloneNet assets (5-year summary)
Cash and deposits¥1.5bnat 2022-06-30StandaloneCash and deposits
Cash and deposits¥1.8bnat 2021-12-31StandaloneCash and deposits
Cash & equivalents¥1.5bnat 2022-06-30StandaloneCash and cash equivalents
Cash & equivalents¥1.8bnat 2021-12-31StandaloneCash and cash equivalents
Cash & equivalents¥2.3bnat 2021-06-30StandaloneCash and cash equivalents
Cash & equivalents¥2.7bnat 2020-12-31dStandaloneCash and cash equivalents
Operating cash flow−¥660m2022-01-01 → 2022-06-30StandaloneNet cash provided by used in operating activities
Operating cash flow−¥1.1bn2021-01-01 → 2021-12-31StandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥561m2021-01-01 → 2021-06-30StandaloneNet cash provided by used in operating activities
Investing cash flow−¥35m2021-01-01 → 2021-12-31StandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow¥341m2022-01-01 → 2022-06-30StandaloneNet cash provided by used in financing activities
Financing cash flow¥271m2021-01-01 → 2021-12-31StandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥176m2021-01-01 → 2021-06-30StandaloneNet cash provided by used in financing activities
EPS (basic)¥-18.172022-01-01 → 2022-06-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-6.532022-04-01 → 2022-06-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-36.742021-01-01 → 2021-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-10.162021-01-01 → 2021-06-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-6.162021-04-01 → 2021-06-30dStandaloneBasic earnings loss per share (5-year summary)
Equity ratio75.3%at 2022-06-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio79.4%at 2021-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio85.3%at 2021-06-30StandaloneEquity to asset ratio (5-year summary)
Shares issued43,057,600at 2022-06-30StandaloneTotal number of issued shares (5-year summary)
Shares issued40,781,500at 2021-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued40,291,500at 2021-06-30StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 18
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment profit2022-01-01 → 2022-06-30−¥239m
jpcrp040300-q2r_E26096-000Drug Discovery And Developmentreportable segmentsegment profit2022-01-01 → 2022-06-30−¥691m
jpcrp040300-q2r_E26096-000Drug Discovery Supportreportable segmentrevenue2022-01-01 → 2022-06-30¥278m
jpcrp040300-q2r_E26096-000Drug Discovery Supportreportable segmentrevenue external2022-01-01 → 2022-06-30¥278m
jpcrp040300-q2r_E26096-000Drug Discovery Supportreportable segmentsegment profit2022-01-01 → 2022-06-30¥151m
Total Of Reportable Segments And Otherssegment totalrevenue2022-01-01 → 2022-06-30¥278m
Total Of Reportable Segments And Otherssegment totalrevenue external2022-01-01 → 2022-06-30¥278m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-01-01 → 2022-06-30−¥540m
Reconciling Itemsreconcilingsegment profit2021-01-01 → 2021-06-30−¥215m
jpcrp040300-q2r_E26096-000Drug Discovery And Developmentreportable segmentrevenue2021-01-01 → 2021-06-30¥103m
jpcrp040300-q2r_E26096-000Drug Discovery And Developmentreportable segmentrevenue external2021-01-01 → 2021-06-30¥103m
jpcrp040300-q2r_E26096-000Drug Discovery And Developmentreportable segmentsegment profit2021-01-01 → 2021-06-30−¥356m
jpcrp040300-q2r_E26096-000Drug Discovery Supportreportable segmentrevenue2021-01-01 → 2021-06-30¥282m
jpcrp040300-q2r_E26096-000Drug Discovery Supportreportable segmentrevenue external2021-01-01 → 2021-06-30¥282m
jpcrp040300-q2r_E26096-000Drug Discovery Supportreportable segmentsegment profit2021-01-01 → 2021-06-30¥156m
Total Of Reportable Segments And Otherssegment totalrevenue2021-01-01 → 2021-06-30¥385m
Total Of Reportable Segments And Otherssegment totalrevenue external2021-01-01 → 2021-06-30¥385m
Total Of Reportable Segments And Otherssegment totalsegment profit2021-01-01 → 2021-06-30−¥201m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 436
ItemContextValueUnit
Industry code when financial statements are prepared in accordance with industry specific regulationsFilingDateInstantCTE
Current fiscal year start dateFilingDateInstant2022-01-01
Current period end dateFilingDateInstant2022-06-30
Type of current periodFilingDateInstantQ2
Current fiscal year end dateFilingDateInstant2022-12-31
Previous fiscal year start dateFilingDateInstant2021-01-01
Comparative period end dateFilingDateInstant2021-06-30
Previous fiscal year end dateFilingDateInstant2021-12-31
Next fiscal year start dateFilingDateInstant－
End date of quarterly or semi annual period of next fiscal yearFilingDateInstant－
Amendment flagFilingDateInstantfalse
Identification of document subject to amendmentFilingDateInstant－
Report amendment flagFilingDateInstantfalse
Xbrl amendment flagFilingDateInstantfalse
Business results of reporting company (text)FilingDateInstantText · Plus
Description of business (text)FilingDateInstantText · Plus
Business risks (text)FilingDateInstantText · Plus
Management analysis of financial position operating results and cash flows (text)FilingDateInstantText · Plus
Critical contracts for operation (text)FilingDateInstantText · Plus
Total number of shares (text)FilingDateInstantText · Plus
Issued shares total number of shares etc (text)FilingDateInstantText · Plus
Class issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember
Original text (Japanese)普通株式
Name of financial instruments exchange on which securities are listed or authorized financial instruments business association to which securities are registeredFilingDateInstant_OrdinaryShareMember
Original text (Japanese)東京証券取引所（グロース市場）
Description issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember
Original text (Japanese)単元株式数は100株であります。
Details of employee share option program (text)FilingDateInstantText · Plus
Other information on share acquisition rights (text)FilingDateInstantText · Plus
Exercises etc of moving strike convertible bonds etc (text)FilingDateInstantText · Plus
Changes in number of issued shares stated capital etc (text)FilingDateInstantText · Plus
Major shareholders (text)FilingDateInstantText · Plus
Name major shareholdersCurrentQuarterInstant_No1MajorShareholdersMember
Original text (Japanese)楽天証券株式会社
Address major shareholdersCurrentQuarterInstant_No1MajorShareholdersMember
Original text (Japanese)東京都港区南青山２丁目６番21号
Name major shareholdersCurrentQuarterInstant_No2MajorShareholdersMember
Original text (Japanese)太田　邦史
Address major shareholdersCurrentQuarterInstant_No2MajorShareholdersMember
Original text (Japanese)東京都板橋区
Name major shareholdersCurrentQuarterInstant_No3MajorShareholdersMember
Original text (Japanese)株式会社SBI証券
Address major shareholdersCurrentQuarterInstant_No3MajorShareholdersMember
Original text (Japanese)東京都港区六本木１丁目６番１号
Name major shareholdersCurrentQuarterInstant_No4MajorShareholdersMember
Original text (Japanese)渡邊　賢二
Address major shareholdersCurrentQuarterInstant_No4MajorShareholdersMember
Original text (Japanese)北海道札幌市中央区
Name major shareholdersCurrentQuarterInstant_No5MajorShareholdersMember
Original text (Japanese)飯作　哲男
Address major shareholdersCurrentQuarterInstant_No5MajorShareholdersMember
Original text (Japanese)東京都江東区
Name major shareholdersCurrentQuarterInstant_No6MajorShareholdersMember
Original text (Japanese)松井証券株式会社
Address major shareholdersCurrentQuarterInstant_No6MajorShareholdersMember
Original text (Japanese)東京都千代田区麹町１丁目４番地
Name major shareholdersCurrentQuarterInstant_No7MajorShareholdersMember
Original text (Japanese)SMBC日興証券株式会社
Address major shareholdersCurrentQuarterInstant_No7MajorShareholdersMember
Original text (Japanese)東京都千代田区丸の内３丁目３番１号
Name major shareholdersCurrentQuarterInstant_No8MajorShareholdersMember
Original text (Japanese)吉村　光司
Address major shareholdersCurrentQuarterInstant_No8MajorShareholdersMember
Original text (Japanese)兵庫県神戸市東灘区
Name major shareholdersCurrentQuarterInstant_No9MajorShareholdersMember
Original text (Japanese)山戸　福太郎
Address major shareholdersCurrentQuarterInstant_No9MajorShareholdersMember
Original text (Japanese)大阪府大阪市中央区
Name major shareholdersCurrentQuarterInstant_No10MajorShareholdersMember
Original text (Japanese)小野澤　重雄
Address major shareholdersCurrentQuarterInstant_No10MajorShareholdersMember
Original text (Japanese)神奈川県海老名市
Issued shares voting rights (text)FilingDateInstantText · Plus

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identitynon_consolidated 2021-12-31pass
balance sheet identitynon_consolidated 2022-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2021-12-31pass
statement vs summary · net assetsnon_consolidated 2022-06-30pass
statement vs summary · operating cash flownon_consolidated 2021-01-01/2021-06-30pass
statement vs summary · operating cash flownon_consolidated 2022-01-01/2022-06-30pass
statement vs summary · revenuenon_consolidated 2021-01-01/2021-06-30pass
statement vs summary · revenuenon_consolidated 2022-01-01/2022-06-30pass
statement vs summary · total assetsnon_consolidated 2021-12-31pass
statement vs summary · total assetsnon_consolidated 2022-06-30pass